secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK:        0001062822
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001193125-25-270020
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexicon files prospectus supplement for $75M ATM equity facility; no sales to date
--------------------------------------------------------------------------------

- Filed prospectus supplement for at-the-market offering of up to $75M of common stock through Jefferies LLC.
- No shares have been sold under the facility as of November 6, 2025.
- Legal opinion from Vinson & Elkins L.L.P. on share validity filed as Exhibit 5.1.
- Facility originally established under Open Market Sale Agreement dated December 29, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1062822/000119312525270020/0001193125-25-270020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1062822/000119312525270020/d37543d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-270020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer